ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Second Quarter Fiscal Year 2013 Financial Results  
1/18/2013 6:23:05 AM

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology and antibody expertise, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, January 25, 2013, to discuss ImmunoGen's financial results for the three-month period ended December 31, 2012 – the second quarter of the Company’s 2013 fiscal year.